Amgen’s Statin Intolerance Study May Not Cure What Ails PCSK9 Inhibitors

GAUSS-3 study shows role for Repatha as an alternative for patients with high cholesterol who can’t take statins, but real world impact may be minimal, due to pushback from payers – and even physicians.

More from Clinical Trials

More from R&D